Full-service Contract Research Organisation (CRO)
Biointelect operates as an Australian CRO specializing in early-phase and complex clinical trials for biotech and pharmaceutical companies.
biointelect.comCrawled Nov 17, 2026
Biointelect operates as an Australian CRO specializing in early-phase and complex clinical trials for biotech and pharmaceutical companies.
Biointelect Venturer accelerates Australian vaccine and infectious disease innovation; contact venturer@biointelect.com for inquiries.
Ebivanta Therapeutics develops an mRNA vaccine to prevent Epstein-Barr virus (EBV), which causes infectious mononucleosis and lacks an approved vaccine despite decades of research.
ENA Respiratory Nasal spray to boost natural antiviral defenses and prevent illness in high-risk groups Respiratory viral infections (RVIs) – including influenza, RSV, SARSCoV-2, parainfluenza, endemic coronaviruses, and rhinovirus – remain a major source of global morbidity and mortality, driving millions of illnesses, hospitalisations, and deaths each year across the US, Australia, and other developed […]
Biointelect offers bespoke life sciences and biotech consulting solutions.
Proboxis Bio creates flexible, scalable vaccines against mosquito-borne flaviviruses, including Japanese encephalitis, dengue, Zika, yellow fever, and West Nile virus, which affect billions globally.
Biointelect collaborated with Medicines Australia, AusBiotech, CSIRO, Pfizer, and MSD to address antimicrobial resistance, presented at PharmAus2019.
The Australian Government and the medicines industry aim to reform how Australia evaluates and funds medicines and vaccines to improve access to new technologies.
The 2019 Medicines Policy Symposium discusses challenges and perspectives on valuing new oncology medicines.
This white paper summarises insights from MTPConnet's roundtable on medical technology, regulation, reimbursement, commercialisation & implementation.
Biointelect outlines key findings on cancer survivorship in Australia, including available programs, challenges, and solutions.
Biointelect received a $32.9 million MRFF grant to support early-stage Australian companies developing vaccine and immune-related therapies.
Biointelect and CR2O forge a strategic partnership to provide advanced end-to-end commercialisation solutions for the life science sector globally.
Biointelect Venturer, funded by a $32.9 million Australian Government grant, opens applications for local infectious disease innovators.
Round 2 of Biointelect Venturer’s funding applications opens on 21 September 2026 for Australian SMEs and innovators.
Biointelect and Health Security Systems Australia signed a memorandum to strengthen collaboration in Australia’s health security and innovation ecosystem.
Biointelect Venturer funds six Australian infectious disease technologies with $10.48 million through the MRFF-backed incubation program.
Biointelect offers life science consulting roles to address industry challenges.
Biointelect’s team of experienced leaders contributes to health policy, commercialization, and regulatory strategy.
Biointelect’s team combines decades of experience across innovative health projects.
Biointelect provides strategic advice for the medical device and biopharma industry.
Biointelect Venturer operates under a governance framework overseen by the Biointelect Board and CEO, guided by the Steering Committee.
Biointelect highlights gaps in early-to-mid-stage vaccine and infectious disease development, where traditional grants often fail to support commercial outcomes.
Biointelect Venturer is a national virtual incubator advancing Australian innovations in infectious disease prevention, funded by a $32.9 million MRFF grant.
Biointelect provides tailored life science consulting services.
Biointelect is an Australian consulting firm specializing in full-service Contract Research Organisation (CRO) capabilities and commercialization support for health innovations.
Biointelect protects personal information collected from employees, contractors, and the public, adhering to privacy obligations.
Biointelect commits to child safety standards, aligning with the National Principles for Child Safe Organizations.